2012

  • Mura M, Engelbrecht LA, Tan HS, Papadaki T, Van den Berg TJTP, de Smet MD: Straylight as a means of assessing visual handicap induced by floaters. Ophthalmology (in press).
  • Aerts F, Noppen B, Fonteyn L, Derua R, Waelkens E, de Smet MD, Vanhove M. Mechanism of inactivation of ocriplasmin in porcine vitreous. Biophys Chem (in print) 2012. PMID: 22445213.
  • de Smet MD, Langner-Wegscheider B: Surgical management of ocular juvenile idiopathic arthritis. Ocul Immunol Inflam (in print) 2012.
  • Aerts F Noppen B, Fonteyn L, Derua R, Hoa NT, Waelkens E, de Smet MD, Long C, Stassen JM, Vanhove M.: Mechanism of inactivation of ocriplasmin in porcine vitreous. Biophys Chem  165-166: 30-38, 2012.  doi:10.1016/j.bpc.2012.03.002. PMID: 22445213.
  • de Smet MD. Corticosteroid intravitreal implants. Dev Ophthalmol 51:122-133, 2012.
  • Gad Elkareem AM, de Smet MD: Effect of microplasmin on the clearance of vitreous hemorrhage from an experimental model in rabbits. Acta Ophthalmol (in press), 2012. doi: 10.1111/j.1755-3768.2012.02568x PMID:23025384
  • Julian K, Langner-Wegscheider, B J, Hass A, de Smet MD: Intravitreal methotrexate in the management of presumed tuberculous serpiginous-like choroiditis. Retina (in press) 2012.
  • de Smet MD, Jonckx B, Vanhove M, van Calster J, Stahlmans P, Stassen JM.: Pharmacokinetics of ocriplasmin in vitreous. Invest Ophthalmol Vis Sci 53:8208-8213, 2012. doi: 10.1167/iovs. 12-10148 PMID: 23150619
  • Mateo-Montoya A, Baglivo E, de Smet MD: Intravitreal methotrexate for the treatment of choroidal neovascularization in multifocal choroiditis. Eye (in press) 2012. doi: 10.1038/eye.2012.262  PMID: 23222567